- Motley Fool•2 days ago
Which of these diabetes-focused companies is the better bet for new money today?
- Motley Fool•3 days ago
The industry leaders' mistakes are lessons for investors.
- Zacks•8 days ago
MannKind (MNKD) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
MNKD : Summary for MannKind Corporation - Yahoo Finance
MannKind Corporation (MNKD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.63 x 7000|
|Ask||0.65 x 100|
|Day's Range||0.63 - 0.67|
|52 Week Range||0.41 - 2.24|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.40|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|